BioSpace
Sr. Director, US Value & Access Strategy, Enzyme Therapies
BioSpace, San Rafael, California, United States, 94911
Sr. Director, US Value & Access Strategy, Enzyme Therapies
The Market Access Strategy Sr. Director will lead US value, access, and reimbursement strategy development to ensure optimal patient access, coverage, reimbursement for BioMarin’s Enzyme Therapies business unit. This individual will play a critical role in aligning cross functional teams, managing payer and channel strategies, and shaping the external market access environment to support product value and commercial success. This position reports to the Vice President of US Market Access. This position drives strategies to ensure market access success by objectively evaluating the US coverage and reimbursement environment and providing subject matter expertise to influence commercial planning and market entry plans. The position identifies access issues and opportunities, and collaborates with commercial/cross-functional teams that address them. Responsibilities
Develop and execute U.S. market access strategies to support product launches and ongoing commercialization. Lead payer engagement strategy, including national and regional commercial payers, PBMs, Medicare and Medicaid Partner with pricing, HEOR, government affairs, patients services and field access teams to develop compelling value propositions and evidence plans. Oversee the development of access-related tools and resources (AMCP dossiers, value decks, coverage policies) Collaborate closely with the sales, marketing, medical affairs, and legal teams to ensure alignment on strategy and execution. Monitor policy, reimbursement, and pricing landscape and assess implications for the business. Support contracting strategy development and assist with negotiations as needed. Manage relationships with external vendors, consultants and payer advisors. Analyze access and utilization data to inform strategy and measure performance. Actively serve as US market access SME/voice for the enzyme therapies business unit in the commercial organization. Required Experience/Skills
Minimum 10+ years of progressive experience in US market access, managed markets, payer strategy or related pharmaceutical functions. Deep understanding of U.S. healthcare system, reimbursement mechanisms, and payer landscape. Deep understanding of health policy & health system environment for transformative and rare therapies. Superior problem-solving skills, including demonstrated capability of applying previous experience to complex policy issues. Excellent communication, collaboration, influence, strategic and analytical skills are required. Ability to lead cross-functional teams in a fast-paced, dynamic environment. Preferred Qualifications
US launch experience in specialty therapeutics (Oncology, rare disease, immunology) Experience with Medicare Part B/D, Medicaid and commercial payers Familiarity with ICER, QALY models, and evidence-based value frameworks Understanding of value-based contracting and innovative reimbursement models Education
Bachelors, preferably in life sciences or economics MBA or MPH, preferred Additional
This position is physically located in BioMarin’s corporate offices in San Rafael, CA, with travel approximately 25% This position has no direct reports Equal Opportunity Employer/Veterans/Disabled
#J-18808-Ljbffr
The Market Access Strategy Sr. Director will lead US value, access, and reimbursement strategy development to ensure optimal patient access, coverage, reimbursement for BioMarin’s Enzyme Therapies business unit. This individual will play a critical role in aligning cross functional teams, managing payer and channel strategies, and shaping the external market access environment to support product value and commercial success. This position reports to the Vice President of US Market Access. This position drives strategies to ensure market access success by objectively evaluating the US coverage and reimbursement environment and providing subject matter expertise to influence commercial planning and market entry plans. The position identifies access issues and opportunities, and collaborates with commercial/cross-functional teams that address them. Responsibilities
Develop and execute U.S. market access strategies to support product launches and ongoing commercialization. Lead payer engagement strategy, including national and regional commercial payers, PBMs, Medicare and Medicaid Partner with pricing, HEOR, government affairs, patients services and field access teams to develop compelling value propositions and evidence plans. Oversee the development of access-related tools and resources (AMCP dossiers, value decks, coverage policies) Collaborate closely with the sales, marketing, medical affairs, and legal teams to ensure alignment on strategy and execution. Monitor policy, reimbursement, and pricing landscape and assess implications for the business. Support contracting strategy development and assist with negotiations as needed. Manage relationships with external vendors, consultants and payer advisors. Analyze access and utilization data to inform strategy and measure performance. Actively serve as US market access SME/voice for the enzyme therapies business unit in the commercial organization. Required Experience/Skills
Minimum 10+ years of progressive experience in US market access, managed markets, payer strategy or related pharmaceutical functions. Deep understanding of U.S. healthcare system, reimbursement mechanisms, and payer landscape. Deep understanding of health policy & health system environment for transformative and rare therapies. Superior problem-solving skills, including demonstrated capability of applying previous experience to complex policy issues. Excellent communication, collaboration, influence, strategic and analytical skills are required. Ability to lead cross-functional teams in a fast-paced, dynamic environment. Preferred Qualifications
US launch experience in specialty therapeutics (Oncology, rare disease, immunology) Experience with Medicare Part B/D, Medicaid and commercial payers Familiarity with ICER, QALY models, and evidence-based value frameworks Understanding of value-based contracting and innovative reimbursement models Education
Bachelors, preferably in life sciences or economics MBA or MPH, preferred Additional
This position is physically located in BioMarin’s corporate offices in San Rafael, CA, with travel approximately 25% This position has no direct reports Equal Opportunity Employer/Veterans/Disabled
#J-18808-Ljbffr